Suppr超能文献

多发性硬化症伴突发性感音神经性听力损失的管理:一例双侧听力损失患者的综合病例报告及文献综述

Management of Sudden Sensorineural Hearing Loss in Multiple Sclerosis: A Comprehensive Case Report of a Patient with Bilateral Loss and Literature Review.

作者信息

Kim Ikhee, Kim Hantai

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Konyang University College of Medicine, Daejeon 35365, Republic of Korea.

Department of Medicine, the Graduate School of Konyang University, Daejeon 35365, Republic of Korea.

出版信息

Life (Basel). 2024 Jan 3;14(1):83. doi: 10.3390/life14010083.

Abstract

In multiple sclerosis (MS), the occurrence of sudden sensorineural hearing loss (SSNHL) is considered rare, with reported cases predominantly being unilateral. Bilateral cases are even rarer. Here, we report a case of bilateral SSNHL in a 20-year-old male diagnosed with MS. The patient, undergoing corticosteroid therapy for the management of MS, additionally received an intratympanic dexamethasone injection; however, it could not achieve significant improvement. Subsequently, the systemic dosage was increased for one week, resulting in substantial hearing improvement in both ears after three months. A review of MS-related SSNHL cases from 1987 to 2022 revealed 39 ears in the literature, with only five ears showing no hearing recovery. A remarkable 87.2% exhibited restored hearing, presenting a more favorable prognosis compared with idiopathic SSNHL. Although there were slight variations in administration methods and duration, all documented treatment approaches involve systemic corticosteroids. In some instances, SSNHL manifested as the initial symptom of MS. When SSNHL occurs in MS, auditory brainstem response (ABR) tests may reveal prolonged abnormalities, making ABR testing effective in cases where MS is suspected following SSNHL. In conclusion, the treatment of MS-related SSNHL appears appropriate with systemic corticosteroids, showing a significantly superior prognosis compared with idiopathic SSNHL.

摘要

在多发性硬化症(MS)中,突发性感音神经性听力损失(SSNHL)的发生被认为较为罕见,报告的病例主要为单侧性。双侧病例更为罕见。在此,我们报告一例20岁男性双侧SSNHL病例,该患者被诊断为MS,正在接受皮质类固醇治疗以控制MS,还接受了鼓室内地塞米松注射;然而,听力并未显著改善。随后,全身用药剂量增加了一周,三个月后双耳听力有了显著改善。对1987年至2022年与MS相关的SSNHL病例回顾发现,文献中有39耳,只有5耳听力未恢复。高达87.2%的病例听力恢复,与特发性SSNHL相比预后更有利。尽管给药方法和持续时间存在细微差异,但所有记录的治疗方法均涉及全身皮质类固醇。在某些情况下,SSNHL表现为MS的首发症状。当MS患者出现SSNHL时,听觉脑干反应(ABR)测试可能显示异常延长,这使得ABR测试在SSNHL后怀疑MS的病例中很有效。总之,全身皮质类固醇治疗MS相关的SSNHL似乎是合适的,与特发性SSNHL相比预后明显更好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验